155 related articles for article (PubMed ID: 28977441)
1. Ageing as a risk factor for ALS/FTD.
Niccoli T; Partridge L; Isaacs AM
Hum Mol Genet; 2017 Oct; 26(R2):R105-R113. PubMed ID: 28977441
[TBL] [Abstract][Full Text] [Related]
2. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
3. Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
Deng Z; Sheehan P; Chen S; Yue Z
Mol Neurodegener; 2017 Dec; 12(1):90. PubMed ID: 29282133
[TBL] [Abstract][Full Text] [Related]
4. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Weishaupt JH; Hyman T; Dikic I
Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
[TBL] [Abstract][Full Text] [Related]
5. Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.
Verma A
Neurol India; 2014; 62(4):347-51. PubMed ID: 25237937
[TBL] [Abstract][Full Text] [Related]
6. Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Haukedal H; Freude K
J Mol Biol; 2019 Apr; 431(9):1818-1829. PubMed ID: 30763568
[TBL] [Abstract][Full Text] [Related]
7. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
Ji AL; Zhang X; Chen WW; Huang WJ
J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder.
Gao FB; Almeida S; Lopez-Gonzalez R
EMBO J; 2017 Oct; 36(20):2931-2950. PubMed ID: 28916614
[TBL] [Abstract][Full Text] [Related]
9. SnapShot: Genetics of ALS and FTD.
Guerreiro R; Brás J; Hardy J
Cell; 2015 Feb; 160(4):798-798.e1. PubMed ID: 25679767
[TBL] [Abstract][Full Text] [Related]
10. [Overlapping features of frontotemporal dementia and amyotrophic lateral sclerosis].
Lillo P; Matamala JM; Valenzuela D; Verdugo R; Castillo JL; Ibáñez A; Slachevsky A
Rev Med Chil; 2014 Jul; 142(7):867-79. PubMed ID: 25378006
[TBL] [Abstract][Full Text] [Related]
11. Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD).
Lattante S; Ciura S; Rouleau GA; Kabashi E
Trends Genet; 2015 May; 31(5):263-73. PubMed ID: 25869998
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of ALS and FTD: implications for translational studies.
Liščić RM
Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy.
Lee A; Rayner SL; Gwee SSL; De Luca A; Shahheydari H; Sundaramoorthy V; Ragagnin A; Morsch M; Radford R; Galper J; Freckleton S; Shi B; Walker AK; Don EK; Cole NJ; Yang S; Williams KL; Yerbury JJ; Blair IP; Atkin JD; Molloy MP; Chung RS
Cell Mol Life Sci; 2018 Jan; 75(2):335-354. PubMed ID: 28852778
[TBL] [Abstract][Full Text] [Related]
14. UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia.
Fecto F; Siddique T
Muscle Nerve; 2012 Feb; 45(2):157-62. PubMed ID: 22246868
[TBL] [Abstract][Full Text] [Related]
15. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.
Le Ber I; De Septenville A; Millecamps S; Camuzat A; Caroppo P; Couratier P; Blanc F; Lacomblez L; Sellal F; Fleury MC; Meininger V; Cazeneuve C; Clot F; Flabeau O; LeGuern E; Brice A;
Neurobiol Aging; 2015 Nov; 36(11):3116.e5-3116.e8. PubMed ID: 26476236
[TBL] [Abstract][Full Text] [Related]
16. Modeling ALS and FTD with iPSC-derived neurons.
Lee S; Huang EJ
Brain Res; 2017 Feb; 1656():88-97. PubMed ID: 26462653
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal Dysfunction at the Centre of Parkinson's Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
Wallings RL; Humble SW; Ward ME; Wade-Martins R
Trends Neurosci; 2019 Dec; 42(12):899-912. PubMed ID: 31704179
[TBL] [Abstract][Full Text] [Related]
18. Targeted high-throughput sequencing identifies a TARDBP mutation as a cause of early-onset FTD without motor neuron disease.
Synofzik M; Born C; Rominger A; Lummel N; Schöls L; Biskup S; Schüle C; Grasshoff U; Klopstock T; Adamczyk C
Neurobiol Aging; 2014 May; 35(5):1212.e1-5. PubMed ID: 24300238
[TBL] [Abstract][Full Text] [Related]
19. Impaired protein degradation in FTLD and related disorders.
Götzl JK; Lang CM; Haass C; Capell A
Ageing Res Rev; 2016 Dec; 32():122-139. PubMed ID: 27166223
[TBL] [Abstract][Full Text] [Related]
20. Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models.
Tan Q; Yalamanchili HK; Park J; De Maio A; Lu HC; Wan YW; White JJ; Bondar VV; Sayegh LS; Liu X; Gao Y; Sillitoe RV; Orr HT; Liu Z; Zoghbi HY
Hum Mol Genet; 2016 Dec; 25(23):5083-5093. PubMed ID: 28007900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
